Nigerian Medical Advocates Rally on Capitol Hill for J-1 Visa Fix and Immigrant Physician Bill
This initiative comes amid targets on international students at U.S. universities and growing concerns over the increasing number of J-1 visa denials, which prevent qualified international medical graduates (IMGs)—especially Nigerian-trained physicians—from contributing their expertise to underserved and rural communities across the United States. Nigerian American physicians have played an important role in filling healthcare shortages in the United States and the advancement of our country's healthcare system is dependent on the removal of systemic barriers to their continued service.
"Doctors from Nigeria and across Africa have long served in America's most vulnerable communities—from inner cities to remote rural counties," said Dr. Susan Edionwe. "Fixing the J-1 process and passing H.R. 1201 is essential to ensuring our communities have access to the care they desperately need."
"NPAG encourages policymakers, allies, and the media to recognize the indispensable contribution of Nigerian and African-trained doctors to the American healthcare system—and to take legislative action to protect and expand their role in advancing national health equity," said Dr. Susan Edionwe.
About Conrad State 30 and Physician Access Reauthorization Act (H.R. 1201): H.R. 1201 a bipartisan bill, would reauthorize and expand the Conrad 30 waiver program, which allows J-1 physicians to remain in the U.S. after residency by serving in Health Professional Shortage Areas (HPSAs). The legislation provides states with greater flexibility, increases waiver caps, and reduces processing delays—ensuring medically underserved communities continue receiving essential care.
About NPAG: The Nigerian Physician Advocacy Group is a national coalition of Nigerian American doctors and advocates committed to advancing health equity, shaping inclusive immigration policy, and addressing physician workforce challenges in the United States.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nigerian-medical-advocates-rally-on-capitol-hill-for-j-1-visa-fix-and-immigrant-physician-bill-302476909.html
SOURCE Nigerian Physician Advocacy Group (NPAG)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Summer Covid cases are rising across the U.S. — Is it time for a vaccine?
As Covid cases begin to rise this summer, many may be wondering: What are my risks, and is it time to get another vaccine? As of July 15, Covid cases were growing or likely growing in 27 states including Texas, Illinois, Kentucky, Virginia and Ohio, according to the Centers for Disease Control and Prevention. Rates of positive Covid tests have also been increasing in recent weeks, the CDC says, specifically in the southern region of the country. N.B.1.8.1 is the current dominant variant in the United States, accounting for 43% of all new Covid cases, according to the CDC. It's an offshoot of the XVD.1.5.1 strain, a descendant of the omicron variant. N.B.1.8.1 was responsible for a surge in hospitalizations in China earlier this year. It's been nicknamed 'razor blade throat,' as there have been anecdotal reports of some people getting painful sore throats, said Dr. William Schaffner, an infectious disease expert at Vanderbilt University Medical Center in Nashville, Tennessee. Schaffner noted, however, that sore throats have been a common symptom of Covid since it first began spreading. 'I doubt the clinical spectrum of Covid has changed substantially,' Schaffner said. Do I need a Covid booster? When will the new vaccines be available? The uptick in cases comes as many Americans have likely gone a year or longer without a Covid shot. In May, the Food and Drug Administration asked drugmakers to update their Covid vaccines to target the LP.8.1 strain, a descendent of JN.1, which began spreading widely in 2023 and is another offshoot of omicron. LP.8.1 currently accounts for 31% of all new cases, per the CDC. The new shots won't be available until the fall, and are expected to be approved only for adults 65 and up and kids and adults with at least one medical condition that puts them at risk of severe illness. Healthy kids and adults who want a shot may have to find an older version or pay out of pocket. A single dose can cost as much as $140. Experts say, however, that population immunity — whether from vaccination, prior infection or both — may shield much of the public for now. 'While we don't have a lot of high level of immunity in the population right now, because it's been so long, we may have enough low level immunity to just make it a little bit harder for that virus to transmit easily from person to person,' said Andy Pekosz, an infectious disease researcher at Johns Hopkins University. Indeed, weekly hospitalization rates have remained low, suggesting that the new variant may not be leading to severe illness. The number of cases are still drastically lower than those this time last year, when the test positivity rate peaked in August at 17.9%. The 2025 season has yet to scrape 5%. Pekosz said it isn't unusual for cases to rise during the summer time, when people are likely to crowd indoors to escape the heat. However, he believes that if there is a summer surge of cases, it will be a small one. 'The variants have been around for a while and haven't caused any major surges up until date,' Pekosz said. 'So again, I'm hopeful that if we see a surge, it'll be a low level surge compared to previous years.' Dr. Ofer Levy, director of the precision vaccines program at Boston Children's Hospital, who has advised the FDA, said people who are at high risk of severe illness still may want to consider getting a Covid shot, if they can find one. High risk groups include: Older adults People with weakened immune systems Pregnant women Those with underlying health conditions, such as asthma and heart disease Getting a shot is especially important, Levy said, for those who haven't had one in over a year and whose immunity has likely waned. 'If you're in a high risk group and you're in a state where cases are rising, you may want to just get the first available appointment and get a shot to protect yourself,' he said. People at high risk can then consider getting an additional Covid shot when the updated vaccines are distributed in the fall, he said. Covid has two waves a year Schaffner, of Vanderbilt, said people in the high risk groups may also want to consider wearing a mask during indoor activities, such as the movies. Healthy adults and children may be able to wait longer before getting another shot, Levy added. 'If you're in a lower risk group, that's where things get fuzzy,' he said. 'I mean if you want a vaccine and your health care provider concurs and you can get it.' Dr. Michael Phillips, an infectious disease doctor at NYU Langone, said that he sees mostly immunocompromised and older adults test positive for the virus. For those who haven't gotten a Covid shot in years, Phillips said he doesn't think they should worry just yet. 'If you're younger, otherwise healthy, I think you're OK,' Phillips said. 'If you have underlying pulmonary disease, you know, if you're an older age group, now that's a time when you should be really talking to a doctor and saying, 'Gosh, should I be getting a booster for Covid?'' He said that the amount of positive Covid tests NYU Langone has seen has decreased 40% since February. Fatima Amaeka, a senior analyst at the Center for Outbreak Response Innovation at Johns Hopkins, said she expects the current wave to peak around September. Schaffner said to expect another wave in the late fall and winter. '[Covid] has two increases each year,' he said. 'Everyone is familiar with the winter increase that goes along with flu and RSV.' This article was originally published on Solve the daily Crossword
Yahoo
2 hours ago
- Yahoo
RingConn Gen 2 Now Available on Walmart.com, Bringing Advanced Sleep Apnea Monitoring to More Consumers
LOS ANGELES, July 23, 2025 /PRNewswire/ -- RingConn, a leading smart ring innovator, has officially launched its flagship Gen 2 Smart Ring and accessories on marking a significant milestone in its U.S. retail expansion. This partnership with Walmart, the nation's largest retailer, enhances RingConn's mission to make advanced health technology more accessible to everyday consumers. As one of the fastest-growing categories in consumer technology, smart wearable devices have become a key area of investment for Walmart, supporting improvements in employee safety, warehouse efficiency, and customer service. In response to the rising demand for personalized, preventive health tools, Walmart has steadily expanded its health-focused wearable offerings this year, adding new-generation devices and advanced sleep tracking wearables. The arrival of RingConn marks a significant step in Walmart's ongoing product diversification strategy—moving beyond traditional wrist-worn formats to offer customers a more compact, discreet, and medically insightful solution. Leveraging its leading technology and innovative design, RingConn has quickly established itself as a benchmark brand in the smart ring segment. Unique features such as advanced sleep tracking, an integrated AI health partner, and ultra-lightweight craftsmanship have earned it recognition from over 200,000 users worldwide. The United States—one of the most mature health tech markets, where consumers value data privacy and proactive health management—has long been a core focus for RingConn. The brand has seen rapid growth in the U.S., becoming a trusted name in smart rings. With its launch on RingConn will leverage Walmart's scale to reach a broad, diverse consumer base and accelerate its North American expansion. The RingConn Gen 2 Smart Ring, now available at was launched in late 2024 and broke a Kickstarter category record with $4.4 million in crowdfunding. It's the world's first smart ring to offer sleep apnea monitoring. Besides, Gen 2 holds several technical distinctions: Lightest available model at 2-3 grams, and thinnest profile in its category at 2mm Extended battery life of 10-12 days Cross-platform compatibility (Android/iOS) with no subscription fees Advanced menstrual cycle monitoring feature To ensure optimal customer experience, Walmart consumers can first order a sizing kit to determine their perfect fit before purchasing the smart ring. This partnership with Walmart marks an important step in RingConn's mission to make smart, approachable health technology available to consumers. About RingConn Established in 2021, RingConn is a leading personal health technology company dedicated to creating innovative products and services that transform the experience of maintaining personal wellness. Guided by the principle of "Hardware + Software + Services," RingConn aims to provide unique products and services for people's health. View original content to download multimedia: SOURCE RingConn LLC
Yahoo
5 hours ago
- Yahoo
Blood Pressure Cuffs Market worth $1.3 billion in 2032 with 9.0% CAGR
DELRAY BEACH, Fla., July 23, 2025 /PRNewswire/ -- The global Blood Pressure Cuffs Market, valued at US$0.6 billion in 2024 stood at US$0.7 billion in 2025 and is projected to advance at a resilient CAGR of 9.0% from 2025 to 2032, culminating in a forecasted valuation of US$1.3 billion by the end of the period. The increasing global burden of chronic non-communicable diseases, including hypertension, obesity, and cardiovascular disorders, primarily drives the expansion of the blood pressure monitoring market. These conditions significantly increase blood pressure levels, necessitating consistent monitoring and management. Moreover, heightened public and clinical awareness of hypertension and its associated complications has led to greater demand for effective diagnostic and monitoring solutions. Concurrently, market growth is further supported by continuous technological advancements and product innovation by key industry players. These developments include introducing non-invasive, automated, and wearable blood pressure monitoring devices to improve accuracy, usability, and patient compliance. Download PDF Brochure: Browse in-depth TOC on "Blood Pressure Cuffs Market" 376 - Tables 50 - Figures 309 - Pages By type, the blood pressure cuffs market is divided into automated and manual segments. Appropriately validated automated blood pressure measuring devices (BPMDs) are considered the preferred standard for clinical diagnosis and management of hypertension. The growth of the automated segment is primarily fueled by the increasing incidence of cardiovascular diseases and the widespread adoption of advanced technologies that offer greater accuracy, ease of use, and efficiency in blood pressure monitoring. By end users, the blood pressure cuffs market is segmented into hospitals, home care settings, ambulatory care centers, urgent care centers, primary centers, and other end users. As of 2024, the hospitals segment accounted for the largest market share. The large share of the segment can be attributed to the higher purchasing power of hospitals. Hospitals are equipped with advanced monitoring technologies and follow standardized clinical procedures, which ensure reliable blood pressure readings. The growing prevalence of cardiovascular diseases and the increasing number of hospital admissions, especially among the elderly population, further drive demand for high-quality blood pressure cuffs in these settings. By geography, the blood pressure cuffs market is segmented into five regional segments: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is expected to grow at the highest CAGR of 10.8% during the forecast period. This rapid expansion is driven by several key factors, including emerging economies such as China, India, and Japan, which are experiencing a surge in healthcare demand. The rising incidence of chronic illnesses, particularly hypertension, and cardiovascular diseases, combined with a growing awareness of early diagnosis and disease prevention, is fueling market growth in the region. Request Sample Pages : The prominent players in the blood pressure cuffs market include OMRON Corporation, Inc. (Japan), Baxter International, Inc. (US), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies, Inc. (US), and McKesson Corporation. (US), B Braun Melsungen AG (Germany), Halma plc (Uk), OSI Systems, Inc. (US), American Diagnostic Corporation (US), Medline Industries, LP. (US), Microlife Corporation (Switzerland), BIOS Medical (UK), ACCOSON (UK), CellBios (India), and Midmark Corporation (US), among others. BAXTER INTERNATIONAL INC. (US): Baxter International Inc., through its subsidiaries, provides a broad range of essential healthcare products, including diagnostic & patient monitoring technologies and respiratory care devices. These products are used in diverse healthcare environments such as hospitals, nursing homes, rehabilitation centers, ambulatory surgical centers, physicians' offices, and home care settings under medical supervision. The company operates globally through four main segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The Healthcare Systems and Technologies segment—connected care solutions, collaboration platforms, monitoring systems, and diagnostic tools such as blood pressure cuffs—is a key component of Baxter's overall strategy. OMRON CORPORATION (JAPAN) OMRON Corporation is a global leader known for offering a diverse portfolio of products across multiple industries. The company operates through four primary business segments: Industrial Automation, Healthcare Business, Social Systems, Solutions and Service Business, and Device & Module Solutions Business. OMRON Healthcare Co., Ltd., a subsidiary of Omron Corporation, specializes in medical devices and health management solutions. This division is recognized as a market leader in cardiovascular care, respiratory health, pain management, remote patient monitoring, and home healthcare equipment—particularly blood pressure monitors. MCKESSON CORPORATION (US) McKesson Corporation and its subsidiaries are a prominent provider of diverse healthcare services dedicated to improving patient health outcomes worldwide. The company operates through four main business segments: US Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The Medical-Surgical Solutions segment plays a key role in delivering a wide range of medical-surgical products—including blood pressure cuffs—as well as logistics, distribution, and support services to various healthcare providers such as physician offices, surgical centers, nursing homes, hospital labs, and home health care agencies. McKesson collaborates with manufacturers and channel partners to effectively serve these markets, focusing on key sectors such as primary care, extended care, government, and other healthcare markets. For more information, Inquire Now! Related Reports: Pulse Oximeter Market Patient Monitoring Devices Market Home Healthcare Market Respiratory Care Devices Market Pressure Monitoring Market Get access to the latest updates on Blood Pressure Cuffs Companies and Blood Pressure Cuffs Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter , LinkedIn and Facebook . Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC. 1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content: SOURCE MarketsandMarkets Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
